National Bankshares Has Lowered Expectations for DRI Healthcare Trust (TSE:DHT.UN) Stock Price

DRI Healthcare Trust (TSE:DHT.UN) had its price objective lowered by National Bankshares from C$19.50 to C$17.50 in a research report sent to investors on Thursday,BayStreet.CA reports. National Bankshares currently has an outperform rating on the stock.

A number of other research analysts have also commented on the company. CIBC cut their target price on DRI Healthcare Trust from C$19.50 to C$18.00 and set an “outperform” rating for the company in a research note on Thursday, December 12th. Raymond James reduced their price objective on shares of DRI Healthcare Trust from C$23.00 to C$22.00 in a report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, DRI Healthcare Trust currently has an average rating of “Moderate Buy” and a consensus price target of C$17.94.

DRI Healthcare Trust Stock Performance

Shares of DHT.UN opened at C$12.04 on Thursday. The stock’s 50-day moving average price is C$11.97 and its 200 day moving average price is C$12.57. DRI Healthcare Trust has a 12-month low of C$10.39 and a 12-month high of C$17.43.

DRI Healthcare Trust Company Profile

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term.